UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer

Clinical nuclear medicine, 2019-12, Vol.44 (12), p.956

2019

Link zum Volltext

Verfügbarkeit prüfen

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

The Lancet (British edition), 2023-09, Vol.402 (10408), p.1133-1146

2023

Link zum Volltext

Verfügbarkeit prüfen

Generation of insulin-deficient piglets by disrupting INS gene using CRISPR/Cas9 system

Transgenic research, 2018-06, Vol.27 (3), p.289-300

2018

Link zum Volltext

Verfügbarkeit prüfen

Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia

Annals of hematology, 2021-11, Vol.100 (11), p.2825-2830

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07

Thoracic cancer, 2020-12, Vol.11 (12), p.3482-3489

2020

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Journal of clinical oncology, 2020-02, Vol.38 (5), p.488-495

2020

Link zum Volltext

Verfügbarkeit prüfen

Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection

International journal of cancer, 2012-02, Vol.130 (4), p.948-958

2012

Link zum Volltext

Verfügbarkeit prüfen

5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection

Onkologie, 2013-08, Vol.36 (7-8), p.421

2013

Link zum Volltext

Verfügbarkeit prüfen

Differential efficacy of tyrosine kinase inhibitors (TKIs) according to the types of EGFR mutations and agents in non-small cell lung cancer (NSCLC): A real-world study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21040-e21040

2023

Link zum Volltext

Verfügbarkeit prüfen

Bax Predicts Outcome in Gastric Cancer Patients Treated with 5-fluorouracil, Leucovorin, and Oxaliplatin Palliative Chemotherapy

Digestive diseases and sciences, 2011, Vol.56 (1), p.131-138

2011

Link zum Volltext

Verfügbarkeit prüfen

Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20616-e20616

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of preoperative and prechemotherapy lymphocyte counts to predict outcome of non-small cell lung cancer patients treated with adjuvant chemotherapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20002-e20002

2019

Link zum Volltext

Verfügbarkeit prüfen

Should combination chemotherapy be used in all advanced gastric cancer patients?

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16081-e16081

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16008-e16008

2018

Link zum Volltext

Verfügbarkeit prüfen

Is third-line chemotherapy routine practice in recurrent or metastatic gastric cancer?

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e15558-e15558

2017

Link zum Volltext

Verfügbarkeit prüfen

Acquired hemophilia successfully treated with activated prothrombin complex concentrate and immunosuppressant combination: a case report

Blood coagulation & fibrinolysis, 2012-10, Vol.23 (7), p.669-672

2012

Link zum Volltext

Verfügbarkeit prüfen

Production of genetically modified pigs expressing human insulin and C-peptide as a source of islets for xenotransplantation

Transgenic research, 2019-12, Vol.28 (5-6), p.549-559

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen

Journal of cancer research and clinical oncology, 2023-03, Vol.149 (3), p.1131-1143

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis

Medicine (Baltimore), 2018-09, Vol.97 (39), p.e12588-e12588

2018

Link zum Volltext

Verfügbarkeit prüfen

Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15109-e15109

2015

Link zum Volltext

Verfügbarkeit prüfen

PEARLY: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with early triple-negative breast cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS587-TPS587

2017

Link zum Volltext

Verfügbarkeit prüfen

Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15056-e15056

2014

Link zum Volltext

Verfügbarkeit prüfen

High expression of Bcl-2 to predict poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving CHOP-based chemotherapy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19511-e19511

2015

Link zum Volltext

Verfügbarkeit prüfen

Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?

Acta oncologica, 2015-01, Vol.54 (8), p.1231-1234

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 241

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(217)

Publikationsform

Artikel
(241)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Generation of insulin-deficient piglets by disrupting INS gene using CRISPR/Cas9 system

Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection

5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection

Differential efficacy of tyrosine kinase inhibitors (TKIs) according to the types of EGFR mutations and agents in non-small cell lung cancer (NSCLC): A real-world study

Bax Predicts Outcome in Gastric Cancer Patients Treated with 5-fluorouracil, Leucovorin, and Oxaliplatin Palliative Chemotherapy

Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?

Comparison of preoperative and prechemotherapy lymphocyte counts to predict outcome of non-small cell lung cancer patients treated with adjuvant chemotherapy

Should combination chemotherapy be used in all advanced gastric cancer patients?

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy

Is third-line chemotherapy routine practice in recurrent or metastatic gastric cancer?

Acquired hemophilia successfully treated with activated prothrombin complex concentrate and immunosuppressant combination: a case report

Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke

Production of genetically modified pigs expressing human insulin and C-peptide as a source of islets for xenotransplantation

Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen

The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis

Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?

PEARLY: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with early triple-negative breast cancer

Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?

High expression of Bcl-2 to predict poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving CHOP-based chemotherapy

Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?

Aktive Filter

Suchergebnisse filtern